PCL Inc Sustainability Reports

PCL, Inc. develops and manufactures multiplex in vitro diagnostic medical devices for immunological screening and clinical diagnostics. Its primary offerings include high-risk viral blood screening products, rapid testing kits, and related diagnostic platform services.

Sector: Manufacturing

Country: South Korea

Exchange: Korea Exchange (KOSDAQ)

FIGI: BBG00FD8LX35

No reports are currently available in our catalogue.